Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: Update;Atualização do tratamento das vasculites associadas a anticorpo anticitoplasma de neutrófilos

Jornal Brasileiro de Pneumologia

Volumn 37, Issue 6, 2011, Pages 809-816

  Santana, Alfredo Nicodemos Cruz ^a   Woronik, Viktoria ^b   Halpern, Ari Stiel Radu ^b   Barbas, Carmen S V ^b  

^a North Wing Regional Hospital   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti neutrophil cytoplasmic antibody associated vasculitis; Antibodies; Antineutrophil cytoplasmic; Wegener granulomatosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; RITUXIMAB;

ANCA ASSOCIATED VASCULITIS; HUMAN; INDUCTION CHEMOTHERAPY; METHODOLOGY; MICROSCOPIC POLYANGIITIS; REVIEW; TIME; WEGENER GRANULOMATOSIS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDUCTION CHEMOTHERAPY; METHOTREXATE; MICROSCOPIC POLYANGIITIS; TIME FACTORS; WEGENER GRANULOMATOSIS;

EID: 84855856209     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132011000600016     Document Type: Review

References (27)

1. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, etal. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 2011;63(4):863-4.
2. Santana AN. Circulating endothelial progenitor cells in ANCA-associated vasculitis: the light at the end of the tunnel? Rheumatology (Oxford). 2009;48(10):1183-4.
3. Santana AN, Takagaki TY, Barbas CS. Incidence of fatal venous thromboembolism in antineutrophil cytoplasmic antibody-associated vasculitis. J Bras Pneumol. 2011;37(3):409-411.
4. Santana AN, Ab'Saber AM, Teodoro WR, Capelozzi VL, Barbas CS. Thrombosis in small and medium-sized pulmonary arteries in Wegener's granulomatosis: a confocal laser scanning microscopy study. J Bras Pneumol. 2010;36(6):724-30.
5. Santana AN, Antunes T, Barbas CS. Treatment of ANCA-associated vasculitis. JAMA. 2007;298(23):2739; author reply 2740.
6. Santana AN, Takagaki TY, Barros JM, Antunes T, Parra ER, Capelozzi VL, etal. Re: giant leg ulcer in Wegener's granulomatosis treated with plasmapheresis and skin graft. Dermatol Surg. 2004;30(8):1182-3.
7. Barros JM, Antunes T, Barbas CS. Síndrome de Churg-Strauss. J Bras Pneumol. 2005;31(Suppl 1):S27-S31.
8. Radu AS, Levi M. Anticorpos contra o citoplasma de neutrófilos. J Bras Pneumol. 2005;31(Suppl 1):S16-S20.
9. Barbas CS, Santana AN, Antunes T, Parra ER, Capelozzi VL, Carvalho CR, etal. Avaliação de 98 pacientes com Granulomatose de Wegener. XXXIII Congresso Brasileiro de Pneumologia e Tisiologia; 2006. J Bras Pneumol. 2006;32(Suppl 5): S227.
10. Whitaker AN, Emmerson BT, Bunce IH, Nicoll P, Sands JM. Reversal of renal failure in Wegener's granulomatosis cy heparin. Am J Med Sci. 1973;265(5):399-406.
11. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, etal. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628-36.
12. Novack SN, Pearson CM. Cyclophosphamide therapy in Wegener's granulomatosis. N Engl J Med. 1971;284(17):938-42.
13. Stone JH, Kaplan AA, Falk RJ. Initial immunosuppressive therapy in Wegener's granulomatosis and microscopic polyangiitis. In: UpToDate, Basow DS, editor. UpToDate, Waltham, MA, 2011.
14. Stone JH, Falk RJ. Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. In: UpToDate, Basow DS, editor. UpToDate, Waltham, MA, 2011.
15. Stone JH, Falk RJ. Treatment of cyclophosphamide-resistant granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. In: UpToDate, Basow DS, editor. UpToDate, Waltham, MA, 2011.
16. Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007;298(6):655-69.
17. Niles J. Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Clin Exp Immunol. 2011;164 Suppl 1:27-30.
18. Casian A, Jayne D. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis. Curr Opin Rheumatol. 2011;23(1):12-7.
19. Reinhold-Keller E, de Groot K. Use of methotrexate in ANCA-associated vasculitides. Clin Exp Rheumatol. 2010;28(5 Suppl 61):S178-82.
20. Chen M, Kallenberg CG. ANCA-associated vasculitides--advances in pathogenesis and treatment. Nat Rev Rheumatol. 2010;6(11):653-64.
21. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, etal. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36-44.
22. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, etal. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180-8.
23. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, etal. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221-32.
24. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, etal. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310-7.
25. Specks U. Methotrexate for Wegener's granulomatosis: what is the evidence? Arthritis Rheum. 2005;52(8):2237-42.
26. Langford CA, Talar-Williams C, Barron KS, Sneller MC. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. Am J Med. 2003;114(6):463-9.
27. Jones RB, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, etal. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2009;60(7):2156-68.